Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance
Standard fractionated radiotherapy for the treatment of cancer consists of daily irradiation of 2-Gy X-rays, 5 days a week for 5–8 weeks. To understand the characteristics of radioresistant cancer cells and to develop more effective radiotherapy, we established a series of novel, clinically relevant...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BlackWell Publishing Ltd
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462352/ |